Genetic indicators of drug resistance in the highly repetitive genomes of Trichomonas vaginalis and other trichomonads

Citations Over Time

Abstract

Abstract Background Trichomonas vaginalis , the most common non-viral sexually transmitted parasite, causes ~283 million trichomoniasis infections annually and is associated with complications during pregnancy and increased risk of HIV-1 acquisition. The antimicrobial drug metronidazole is used for treatment, but has lead to widespread drug resistance. We undertook sequencing of multiple clinical isolates and lab derived lines to identify genetic markers and mechanisms of metronidazole resistance. Results Reduced representation genome sequencings of more than 100 T. vaginalis clinical isolates identified 3,923 SNP markers and presence of a bipartite population structure. Linkage disequilibrium decays rapidly, suggesting genome-wide recombination and the feasibility of genetic association studies in the parasite. We identified 72 SNPs associated with metronidazole resistance, and a comparison of SNPs within several lab-derived resistant lines revealed an overlap with the clinically resistant isolates. We identified SNPs in sets of genes for which no function has yet been assigned, as well as in functionally-characterized genes highly relevant to drug resistance ( e.g., pyruvate:ferredoxin oxidoreductase ( PFO )). Transcription profiling of these and other genes served as proxy for testing the functional consequences of multiple identified SNPs. Transcription profiles of lab-derived drug resistance strain as well as clinically resistant strain depict common regulation changes in carbohydrate metabolism and oxygen detoxification pathways correlated with Mz resistance. Finally, we identified convergent genetic changes in lab-derived resistant lines of Tritrichomonas foetus , a distantly-related species that causes venereal disease in cattle. Conclusions Our observation of shared genetic changes within and between T. vaginalis and Tr. foetus parasites suggests conservation of the pathways through which adaptation has occurred. These findings extend our knowledge of drug resistance in the parasite, providing a panel of markers that can be used as a diagnostic tool.

Related Papers

• → Three metronidazole-resistant strains of Trichomonas vaginalis from the United States(1980)104 cited
• → An Agar Culture Technique to Quantitate Trichomonas vaginalis from Women(1987)32 cited
• → Metronidazole resistant trichomoniasis successfully treated with paromomycin.(1997)17 cited
• Trichomoniasis. Clinical trial of metronidazole (Flagyl).(1963)
• → Potential of synthetic endoperoxides against Trichomonas vaginalis in vitro(2017)2 cited